Basic Tumor Immunology

Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection
Elham Beyranvand Nejad, Robert B. Ratts, Eleni Panagioti, Christine Meyer, Jennifer D. Oduro, Luka Cicin-Sain, Klaus Früh, Sjoerd H. van der Burg, Ramon Arens

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 25; DOI: 10.1186/s40425-019-0500-9
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins, Marcos Sande, Jens V. Stein, Carsten Riether, Elisa Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kundig, Monique Vogel, Murray A. Skinner, Daniel E. Speiser, Alexander Knuth, Matthias F. Kramer, Martin F. Bachmann

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 114; DOI: 10.1186/s40425-019-0587-z
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
Molly A. Taylor, Adina M. Hughes, Josephine Walton, Anna M. L. Coenen-Stass, Lukasz Magiera, Lorraine Mooney, Sigourney Bell, Anna D. Staniszewska, Linda C. Sandin, Simon T. Barry, Amanda Watkins, Larissa S. Carnevalli, Elizabeth L. Hardaker

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 328; DOI: 10.1186/s40425-019-0794-7
TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways
Yuxue Jiang, Jintong Chen, Enguang Bi, Yinghua Zhao, Tianxue Qin, Yiming Wang, Alison Wang, Sujun Gao, Qing Yi, Siqing Wang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 28; DOI: 10.1186/s40425-018-0494-8
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing, Donna McAllister, Emily P. Vonderhaar, Katie Palen, Matthew J. Riese, Jill Gershan, Bryon D. Johnson, Michael B. Dwinell

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 115; DOI: 10.1186/s40425-019-0573-5
Chemotherapy accelerates immune-senescence and functional impairments of Vδ2^pos T cells in elderly patients affected by liver metastatic colorectal cancer
Elena Bruni, Valentina Cazzetta, Matteo Donadon, Matteo Cimino, Guido Torzilli, Gianmarco Spata, Gloria Leonardi, Francesco Dieli, Joanna Mikulak, Domenico Mavilio

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 347; DOI: 10.1186/s40425-019-0825-4
miR-448 targets IDO1 and regulates CD8⁺ T cell response in human colon cancer
Qiong Lou, Ruixian Liu, Xiangling Yang, Weiqian Li, Lanlan Huang, Lili Wei, Huiliu Tan, Nanlin Xiang, Kawo Chan, Junxiong Chen, Huanliang Liu

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 210; DOI: 10.1186/s40425-019-0691-0
Genetic instability as a driver for immune surveillance
Guim Aguadé-Gorgorió, Ricard Solé

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 345; DOI: 10.1186/s40425-019-0795-6
Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
Xuyao Zhang, Yichen Wang, Jiajun Fan, Wei Chen, Jingyun Luan, Xiaobin Mei, Shaofei Wang, Yubin Li, Li Ye, Song Li, Wenzhi Tian, Kai Yin, Dianwen Ju

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 346; DOI: 10.1186/s40425-019-0812-9
Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
Yinghong Zhai, Xiaofei Ye, Fangyuan Hu, Jinfang Xu, Xiaojing Guo, Yonglong Zhuang, Jia He

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 286; DOI: 10.1186/s40425-019-0754-2

Main menu

Basic Tumor Immunology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Basic Tumor Immunology

Pages